Q2 2024 Holdings
Filed 2024-08-14 | 61 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $1.1K | 66,666 | 0.0% |
| Nuvation Bio Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $42.7K | 266,666 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $200.3K | 250,000 | 0.0% |
| Milestone Pharmaceuticals In(MIST) | COM | 59935V107 | $407.9K | 309,007 | 0.0% |
| BioAtla Inc(BCAB) | COM | 09077B104 | $940.3K | 686,347 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $1.4M | 166,000 | 0.1% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $1.7M | 811,627 | 0.1% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $1.8M | 450,000 | 0.1% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $1.9M | 238,193 | 0.1% |
| Absci Corporation(ABSI) | COM | 00091E109 | $2.2M | 700,000 | 0.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $2.4M | 506,000 | 0.1% |
| Boundless Bio Inc(BOLD) | COM | 10170A100 | $2.8M | 711,329 | 0.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $2.9M | 1,500,000 | 0.2% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $6.0M | 750,000 | 0.3% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $6.9M | 727,900 | 0.4% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $7.0M | 650,000 | 0.4% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $7.9M | 350,000 | 0.4% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $8.4M | 1,545,000 | 0.4% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $9.0M | 3,850,000 | 0.5% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $9.8M | 2,568,287 | 0.5% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $11.5M | 657,895 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $11.9M | 1,819,132 | 0.6% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $12.2M | 1,732,571 | 0.6% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $12.5M | 4,901,603 | 0.7% |
| Poseida Therapeutics(PSTXUSD) | COM | 73730P108 | $13.1M | 4,475,000 | 0.7% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $13.8M | 1,536,341 | 0.7% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $14.2M | 690,000 | 0.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $15.7M | 671,358 | 0.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $15.7M | 400,000 | 0.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $16.2M | 608,614 | 0.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $16.4M | 696,480 | 0.9% |
| Day One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $16.4M | 1,189,943 | 0.9% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $18.5M | 2,603,190 | 1.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $18.7M | 1,590,000 | 1.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $20.6M | 1,000,000 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $21.8M | 825,000 | 1.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $23.4M | 600,000 | 1.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $24.4M | 1,602,200 | 1.3% |
| Geron Corp(GERN) | COM | 374163103 | $25.4M | 6,000,000 | 1.3% |
| Third Harmonic Bio Inc(THRD) | COM | 88427A107 | $26.0M | 2,000,000 | 1.4% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $26.6M | 600,000 | 1.4% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $26.9M | 8,215,910 | 1.4% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $31.6M | 1,466,051 | 1.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $32.2M | 400,000 | 1.7% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $32.6M | 1,300,000 | 1.7% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $33.1M | 5,607,350 | 1.7% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $39.3M | 1,676,733 | 2.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $43.0M | 100,000 | 2.3% |
| iTeos Therapeutics Inc(5E7) | COM | 46565G104 | $43.7M | 2,946,915 | 2.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $66.2M | 1,726,000 | 3.5% |